Search
for
Sort by
Research 6
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment